Prevalence and risk factors of painful diabetic neuropathy: A systematic review and meta-analysis

作者：Yong Tao, Haiyang Zhang, Claire MacGilchrist, Ellen Kirwan, Caroline McIntosh · 发表于：Diabetes Research and Clinical Practice · 年份：2025 · DOI：10.1016/j.diabres.2025.112099 · 被引用次数：41 · 研究领域：Pain Mechanisms and Treatments、Botulinum Toxin and Related Neurological Disorders、Neurological Disorders and Treatments

(OR = 1.62, 95 % CI, 1.43-1.83), longer diabetes duration (OR = 1.05, 95 % CI, 1.01-1.08), and nephropathy (OR = 1.32, 95 % CI, 1.24-1.40). Targeted screening and standardized diagnostic tools are urgently needed to enhance PDPN management and mitigate its burden globally.